Prana Biotechnology (PRAN) Stock: Gaining On Positive Pre-Clinical Data

Prana Biotechnology Limited (ADR) (NASDAQ: PRAN) Prana Biotechnology is enjoying the morning this morning, for sure. After announcing positive pre-clinical data, the stock started to soar. As is nearly always the case, our partners at Trade Ideas were the first to inform us of the gains on the stock. At the moment (9:52), PRAN is … Read more

Morning Buzz: Prana Biotechnology (PRAN), Heron Therapeutics (HRTX), Vascular Biogenics (VBLT), Clovis Oncology (CLVS)

Prana Biotechnology Limited (PRAN) shares surged 19.26% to $1.61 in early trading following the company’s announcement that the European Commission has approved orphan designation for PBT2 for the treatment of Huntington’s disease, stating that Prana has shown that PBT2 might be of significant benefit for patients with Huntington’s disease. Shares of Heron Therapeutics, Inc. (HRTX) … Read more